Remove .Net Remove 2017 Remove Blogging Remove Report
article thumbnail

Xconomy Special Report: 12 San Diego Tech Startup to Watch in 2017

Xconomy

I widened my net this year. The startups selected for this year’s list began, as it did last year, with a master list of companies screened by the San Diego Venture Group for its annual venture summit. I am grateful to Mike Krenn, the venture group’s president, for his help on this project.

article thumbnail

Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More

Xconomy

And once in a while, a defender uses his or her face, inadvertently, to block a ball spiked over the net. The CRISPR news this week doesn’t need a metaphor; the drama that MIT Technology Review reported can stand alone. STAT found the figures in Editas’s quarterly earnings report. Talk about sacrifice.

article thumbnail

Bio Roundup: Mylan’s Shock, Hillary’s 3%, Duchenne Lessons & More

Xconomy

A Phase 2 trial of the drug, AMX0035, should start in late 2016 or early 2017. Frank Vinluan has more on Novan, which relied on a variety of high net worth individuals, rather than venture firms, to get to this point. Alex Lash contributed to this report. Reprints | Share: UNDERWRITERS AND PARTNERS.

Pricing 40